10X Genomics is changing the definition of sequencing by providing an innovative genomics platform that dramatically upgrades the capabilities of existing short read sequencers. The company does this through a combination of elegant microfluidics, chemistry, and bioinformatics. With the GemCode Platform, researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows.
- Location: Pleasanton, CA
- Paladin Initial Investment Date: November 2011